Cellonis Biotechnologies Co. Ltd.
BEIJING, November 3, 2010 - "For brain cancer patients after surgery, the combined DC-CIK and stem
cell therapy from Cellonis Biotechnologies can be a very effective method in
preventing cancer recurrence," says renowned cancer doctor Dr.
BEIJING, August 24, 2010 - Cellonis Biotechnologies, a Beijing and HK-based medical research and
application company, has recorded some remarkable results in the treatment of
a twelve-year-old boy with diabetes using their stem cell therapy in a
Beijing partner hospital.
BEIJING, June 24, 2010 - Cellonis, a Beijing and HK-based biotech company, with its new
personalized diabetes treatment concept has demonstrated an amazing
improvement in their treated patients' conditions.
